Status:
RECRUITING
TAES for FPVCs: a Pragmatic, Randomized Controlled Trial
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Collaborating Sponsors:
China Association for Science and Technology
Conditions:
Premature Ventricular Complexes
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This prospective, randomized controlled trial aims to evaluate the efficacy and safety of Transcutaneous Auricular Vagus Nerve Stimulation (TAVNS) for patients with frequent premature ventricular coom...
Eligibility Criteria
Inclusion
- Diagnosed as frequent premature ventricular contractions;
- 2 ≤ Lown level ≤ 4A;
- 18 ≤ age ≤ 75;
- Volunteered to participant
Exclusion
- Severe valvular disease, congenital heart disease, pericardial disease, hypertrophic cardiomyopathy, unstable angina pectoris, acute myocardial infarction, myocarditis, aneurysm, congestive heart failure decompensation period (NYHA grade III or VI), cardiogenic shock, cerebrovascular disease, hematopoietic system disease, severe mental disease;
- Bradycardia, including pathologic sinus node syndrome, degree II or greater atrioventricular block;
- Those who have already had pacemaker or percutaneous coronary intervention, or who plan to have pacemaker or percutaneous coronary intervention;
- Pregnant or lactating women;
- Local sensory deficit, or allergic to current;
- May be allergic to percutaneous patches；
- Blood pressure ≤ 90/60 mmHg;
- Those who have participated in other clinical trials within 3 months.
Key Trial Info
Start Date :
June 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04415203
Start Date
June 4 2020
End Date
December 1 2025
Last Update
July 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guang'anmen Hospita, China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China, 100053